Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

5,669

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

December 30, 2020

Conditions
Cervical Cancer
Interventions
BEHAVIORAL

Opt-in; Receive offer to order self-sampling kit

Women in the opt-in arm receive an offer to order a HPV self-sampling kit, in addition to information about the study. Women who order, receive a kit that includes a self-sampling brush (Evalyn, Rovers Medical Devices), with instructions for use and a pre-paid envelope for returning the brush for HPV testing. The women are also informed that they can attend ordinary screening, i.e. performed by a physician. Women who choose self-sampling and test positive for high-risk HPV will be 1:1 allocated to follow-up by their general practitioner or a gynecologist. Women who test negative for high-risk HPV return to the ordinary screening program

BEHAVIORAL

Opt-out; Receive self-sampling kit unsolicited

Women in the opt-out arm receive the self-sampling kit directly, without having ordered it themselves. The kit has the same contents, and the follow-up is the same, as that described for the opt-in arm.

BEHAVIORAL

Control; Receive open reminder to be screened by physician

Similar to the procedure of the national screening program, women in the control arm receive a reminder to be screened by their general practitioner, and continues in the ordinary screening program

Trial Locations (1)

0304

Cancer Registry of Norway, Oslo

All Listed Sponsors
collaborator

University Hospital, Akershus

OTHER

collaborator

University of Oslo

OTHER

collaborator

University of Bergen

OTHER

collaborator

Albert Einstein College of Medicine

OTHER

collaborator

Norwegian Institute of Public Health

OTHER_GOV

lead

Oslo University Hospital

OTHER

NCT03873376 - Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening | Biotech Hunter | Biotech Hunter